Literature DB >> 21248254

Accelerated dendritic cell differentiation from migrating Ly6C(lo) bone marrow monocytes in early dermal West Nile virus infection.

Ariane M Davison1, Nicholas J C King.   

Abstract

No study has investigated the participation of Ly6C(+) monocytes in the earliest phase of skin infection with the mosquito-borne West Nile virus. In a novel murine model mimicking natural dermal infection, CCL2-dependent bone marrow (BM)-derived monocyte migration, differentiation into Ly6C(+) dendritic cells (DC), and accumulation around dermal deposits of infected fibroblasts by day 1 postinfection were associated with increasing numbers of monocyte-derived TNF/inducible NO synthase-producing DC by day 2 postinfection in draining auricular lymph nodes (ALN). Adoptive transfer demonstrated simultaneous migration of bone marrow-derived Ly6C(lo) monocytes to virus-infected dermis and ALN, where they first become Ly6C(hi) DC within 24 h and then Ly6C(lo) DC by 72 h. DC migration from the infected dermis to the ALN derived exclusively from Ly6C(lo) BM monocytes. This demonstrates that Ly6C(hi) and Ly6C(lo) BM-derived monocytes have different fates in vivo and suggests that BM may be a reservoir of preinflammatory monocytes for rapid deployment as inflammatory DC during virus infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248254     DOI: 10.4049/jimmunol.1002682

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

Review 2.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

3.  N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.

Authors:  Kothila Tharmarajah; Arun Everest-Dass; Jelena Vider; Xiang Liu; Joseph R Freitas; Helen Mostafavi; Jayaram Bettadapura; Mark von Itzstein; Nicholas P West; Adam Taylor; Suresh Mahalingam; Ali Zaid
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

4.  CD22 is required for protection against West Nile virus Infection.

Authors:  Daphne Y Ma; Mehul S Suthar; Shinji Kasahara; Michael Gale; Edward A Clark
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 5.  Molecular control of monocyte development.

Authors:  Rachael L Terry; Stephen D Miller
Journal:  Cell Immunol       Date:  2014-03-12       Impact factor: 4.868

6.  West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Authors:  S Kovats; S Turner; A Simmons; T Powe; E Chakravarty; J Alberola-Ila
Journal:  Clin Exp Immunol       Date:  2016-09-22       Impact factor: 4.330

7.  Characteristics of "Tip-DCs and MDSCs" and Their Potential Role in Leishmaniasis.

Authors:  Maximilian Schmid; Anja K Wege; Uwe Ritter
Journal:  Front Microbiol       Date:  2012-03-12       Impact factor: 5.640

8.  Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium.

Authors:  Luis Munoz-Erazo; Ricardo Natoli; Jan Marie Provis; Michelle Catherine Madigan; Nicholas Jonathan Cole King
Journal:  Mol Vis       Date:  2012-03-27       Impact factor: 2.367

9.  Comparison of attenuated and virulent West Nile virus strains in human monocyte-derived dendritic cells as a model of initial human infection.

Authors:  Daniel J Rawle; Yin Xiang Setoh; Judith H Edmonds; Alexander A Khromykh
Journal:  Virol J       Date:  2015-03-22       Impact factor: 4.099

Review 10.  Inflammatory monocytes and the pathogenesis of viral encephalitis.

Authors:  Rachael L Terry; Daniel R Getts; Celine Deffrasnes; Caryn van Vreden; Iain L Campbell; Nicholas J C King
Journal:  J Neuroinflammation       Date:  2012-12-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.